Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study

Lupus Science and Medicine

Volumn 1, Issue 1, 2014, Pages

  Compagno, Michele ^a   Rekvig, Ole P ^b   Bengtsson, Anders A ^a   Sturfelt, Gunnar ^a   H Heegaard, Niels H ^c   Jönsen, Andreas ^a   Jacobsen, Rasmus Sleimann ^d   Eilertsen, Gro O ^b   Fenton, Christopher G ^b   Truedsson, Lennart ^a   Nossent, Johannes C ^b,e   Jacobsen, Søren ^d  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF TROMSØ   (Norway)

^c STATENS SERUM INSTITUT   (Denmark)

^d University of Copenhagen   (Denmark)

^e ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA ANTIBODY;

ADOLESCENT; ADULT; AGED; ALOPECIA; ANTIBODY SPECIFICITY; ARTICLE; CONSENSUS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; LINEAR REGRESSION ANALYSIS; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHENOTYPE; PLEURISY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEINURIA; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84937980532     PISSN: None     EISSN: 20538790     Source Type: Journal    
DOI: 10.1136/lupus-2013-000007     Document Type: Article

References (56)

1. Isenberg DA, Ehrenstein MR, Longhurst C, et al. The origin, sequence, structure, and consequences of developing anti-DNA antibodies. A human perspective. Arthritis Rheum 1994;37:169-80.
2. Khalil M, Spatz L, Diamond B. Anti-DNA antibodies. In: Lahita R. ed. Systemic lupus erythematosus. 3rd edn. Academic Press, 1999:197-217.
3. van Bruggen MC, Walgreen B, Rijke TP, et al. Antigen specificity of anti-nuclear antibodies complexed to nucleosomes determines glomerular basement membrane binding in vivo. Eur J Immunol. 1997;27:1564-9.
4. van Bavel CC, Fenton KA, Rekvig OP, et al. Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus. Arthritis Rheum 2008;58:1892-9.
5. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
6. Hahn BH. Antibodies to DNA. N Engl J Med 1998;338:1359-68.
7. Foster MH. T cells and B cells in lupus nephritis. Semin Nephrol 2007;27:47-58.
8. Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677-86.
9. Fenton K, Fismen S, Hedberg A, et al. Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. PLoS One 2009;4:e8474.
10. Fismen S, Hedberg A, Fenton KA, et al. Circulating chromatin-antichromatin antibody complexes bind with high affinity to dermoepidermal structures in murine and human lupus nephritis. Lupus 2009;18:597-607.
11. Grootscholten C, van Bruggen MC, van der Pijl JW, et al. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum 2003;48:1355-62.
12. Huerta PT, Kowal C, DeGiorgio LA, et al. Immunity and behavior: Antibodies alter emotion. Proc Natl Acad Sci USA 2006;103:678-83.
13. Haugbro K, Nossent JC, Winkler T, et al. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: The role of analytical diversity. Ann Rheum Dis 2004;63:386-94.
14. Jang YJ, Stollar BD. Anti-DNA antibodies: Aspects of structure and pathogenicity. Cell Mol Life Sci 2003;60:309-20.
15. Kalsi JK, Martin AC, Hirabayashi Y, et al. Functional and modelling studies of the binding of human monoclonal anti-DNA antibodies to DNA. Mol Immunol 1996;33:471-83.
16. Stollar BD. Immunochemistry of DNA. Int Rev Immunol 1989;5:1-22.
17. Berden JH. Lupus nephritis: consequence of disturbed removal of apoptotic cells? Neth J Med 2003;61:233-8.
18. Fismen S, Mortensen ES, Rekvig OP. Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB x NZW) F1 mice. Immunol Cell Biol 2011;89:90-9.
19. Kruse K, Janko C, Urbonaviciute V, et al. Inefficient clearance of dying cells in patients with SLE: Anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players. Apoptosis 2010;15:1098-113.
20. Munoz LE, Janko C, Schulze C, et al. Autoimmunity and chronic inflammation-two clearance-related steps in the etiopathogenesis of SLE. Autoimmun Rev 2010;10:38-42.
21. Napirei M, Karsunky H, Zevnik B, et al. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 2000;25:177-81.
22. Urbonaviciute V, Furnrohr BG, Meister S, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008;205:3007-18.
23. Van Ghelue M, Moens U, Bendiksen S, et al. Autoimmunity to nucleosomes related to viral infection: A focus on hapten-carrier complex formation. J Autoimmun 2003;20:171-82.
24. Rekvig OP. Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for SLE: critical remarks. Clin Exp Immunol 2014. doi:10.1111/cei.12296
25. Mostoslavsky G, Fischel R, Yachimovich N, et al. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: A case for tissue injury by molecular mimicry. Eur J Immunol 2001;31:1221-7.
26. Amital H, Heilweil M, Ulmansky R, et al. Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol 2005;175:5516-23.
27. Deocharan B, Qing X, Lichauco J, et al. Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 2002;168:3072-8.
28. Mageed RA, Zack DJ. Cross-reactivity and pathogenicity of anti-DNA autoantibodies in systemic lupus erythematosus. Lupus 2002;11:783-6.
29. Sabbaga J, Line SR, Potocnjak P, et al. A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur J Immunol 1989;19:137-43.
30. Kalaaji M, Mortensen E, Jorgensen L, et al. Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am J Pathol 2006;168:1779-92.
31. Lefkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum 1996;39:894-903.
32. Mjelle JE, Rekvig OP, Fenton KA. Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis. Ann Rheum Dis 2007;66:1661-8.
33. Mortensen ES, Fenton KA, Rekvig OP. Lupus nephritis: The central role of nucleosomes revealed. Am J Pathol 2008;172:275-83.
34. Mortensen ES, Rekvig OP. Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes. J Am Soc Nephrol 2009;20:696-704.
35. Seredkina N, Rekvig OP. Acquired loss of renal nuclease activity is restricted to DNaseI and is an organ-selective feature in murine lupus nephritis. Am J Pathol 2011;179:1120-8.
36. Seredkina N, Zykova SN, Rekvig OP. Progression of murine lupus nephritis is linked to acquired renal Dnase1 deficiency and not to up-regulated apoptosis. Am J Pathol 2009;175:97-106.
37. Van Bruggen MC, Kramers C, Berden JH. Autoimmunity against nucleosomes and lupus nephritis. Ann Med Interne (Paris) 1996;147:485-9.
38. van Bruggen MC, Kramers C, Hylkema MN, et al. Pathophysiology of lupus nephritis: The role of nucleosomes. Neth J Med 1994;45:273-9.
39. Radic MZ, Seal SN. Selection of recurrent V genes and somatic mutations in autoantibodies to DNA. Methods 1997;11: 20-6.
40. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
41. Griffith J, Bleyman M, Rauch CA, et al. Visualization of the bent helix in kinetoplast DNA by electron microscopy. Cell 1986;46:717-24.
42. Hirota Y, Ohyama T. Adjacent upstream superhelical writhe influences an Escherichia coli promoter as measured by in vivo strength and in vitro open complex formation. J Mol Biol 1995;254:566-78.
43. Isenberg DA, Dudeney C, Williams W, et al. Measurement of anti-DNA antibodies: A reappraisal using five different methods. Ann Rheum Dis 1987;46:448-56.
44. Tan EM, Smolen JS, McDougal JS, et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum 1999;42:455-64.
45. Werle E, Blazek M, Fiehn W. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae immunofluorescence test. Lupus 1992;1:369-77.
46. Kalaaji M, Sturfelt G, Mjelle JE, et al. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Arthritis Rheum 2006;54:914-26.
47. Zykova SN, Seredkina N, Benjaminsen J, et al. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice. Arthritis Rheum 2008;58:813-25.
48. Kalaaji M, Fenton KA, Mortensen ES, et al. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 2007;71:664-72.
49. Antico A, Platzgummer S, Bassetti D, et al. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test. Lupus 2010;19:906-12.
50. Conrad K, Ittenson A, Reinhold D, et al. High sensitive detection of double-stranded DNA autoantibodies by a modified Crithidia luciliae immunofluorescence test. Ann N Y Acad Sci 2009;1173: 180-5.
51. Kim KH, Han JY, Kim JM, et al. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody. Clin Chim Acta 2007;380:182-5.
52. Neogi T, Gladman DD, Ibanez D, et al. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent. J Rheumatol 2006;33:1785-8.
53. Roggenbuck D, Conrad K, Reinhold D. High sensitive detection of double-stranded DNA antibodies by a modified Crithidia luciliae immunofluorescence test may improve diagnosis of systemic lupus erythematosus. Clin Chim Acta 2010;411:1837-8.
54. Tzioufas AG, Terzoglou C, Stavropoulos ED, et al. Determination of anti-ds-DNA antibodies by three different methods: comparison of sensitivity, specificity and correlation with lupus activity index (LAI). Clin Rheumatol 1990;9:186-92.
55. Compagno M, Jacobsen S, Rekvig OP, et al. Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study. Scand J Rheumatol 2013;42:311-16.
56. Manoussakis MN, Garalea KL, Tzioufas AG, et al. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera. Clin Rheumatol 1988;7:465-9.